Bare

Reflow Medical Receives CE Mark for Bare Temporary Spur Stent System for Treating de novo or Restenotic Below-the-Knee (BTK) Lesions

Retrieved on: 
Tuesday, January 16, 2024
Surgery, Medical Devices, Health, Health Technology, Cardiology, Mortality, Patient, European, Spur, Principal, MD, MDR, Multimedia, Bare, CLTI, RST, Risk, BTK, Quality of life, De novo, Division, Safety, Medicine, Amputation, CE marking, Medical University of Graz, DCB, Wound healing, Cardiovascular disease, Trial of the century, Physician, Pharmaceutical industry

Reflow Medical, Inc., a developer of innovative medical devices focused on cardiovascular disease, announces it has received CE (Conformité Européenne) Mark certification in the European Union for the Bare Temporary Spur Stent System .

Key Points: 
  • Reflow Medical, Inc., a developer of innovative medical devices focused on cardiovascular disease, announces it has received CE (Conformité Européenne) Mark certification in the European Union for the Bare Temporary Spur Stent System .
  • The device is intended to treat de novo or restenotic lesions in the infrapopliteal arteries with a commercially available drug-coated balloon (DCB) to enhance drug absorption.
  • View the full release here: https://www.businesswire.com/news/home/20240116803175/en/
    The Bare Temporary Spur Stent System is a unique clinical solution known as Retrievable Stent Therapy, or RST.
  • The Bare Temporary Spur Stent System is a unique clinical solution intended to provide stent-like results while leaving no metal behind.

First Round of Late-Breaking Clinical Trial Results Announced at VIVA23

Retrieved on: 
Tuesday, October 31, 2023
Atheroma, Peripheral artery disease, Diabetes, Pivotal trial, Ulcer, Transducer, Male, Disease, PAP, Buerger's test, Classification, The Unreconstructed M, IVUS, Amputation, Stent, PAD, PP, Thorpe tube flowmeter, TUS, Calf, Chin Na, Vein, Telephone, TASC, Bare, Vibrato, Life, SP, W. L. Gore & Associates, VIVA, Safety, Patient, Dyslipidemia, Blood vessel, Plaque, History, CLTI, Coronary artery disease, Perfusion, Restenosis, Research, Foot, Spur, Atherectomy, Șaeș, Artery, Education, DCB, Doppler effect, Dialysis, Hypertension, FP, Freedom, Wynn Las Vegas, Wound healing, Medical imaging, Pharmaceutical industry, Birth control, Surveying, Medtronic

Below are highlights of this morning's 5 late-breaking clinical trial presentations.

Key Points: 
  • Below are highlights of this morning's 5 late-breaking clinical trial presentations.
  • At 20 centers without roll-ins across the United States, 105 no-option CLTI patients were enrolled in a nonrandomized manner.
  • The median age was 70 years, two-thirds of the patients were male, and one-quarter of patients were Hispanic or Latino.
  • 1-Year Results of the DEEPER OUS Trial: The Bare Temporary Spur Stent System in Combination With a Paclitaxel-Coated Balloon
    The DEEPER OUS trial is a prospective, nonrandomized, multicenter, single-arm trial taking place in New Zealand, Germany, and Switzerland.

Shatterproof Launches Bare Your Heart Campaign

Retrieved on: 
Friday, September 1, 2023
Technology, Other Health, Health, Philanthropy, General Health, Entertainment, Other Philanthropy, Mental Health, Apps, Applications, Audio, Video, Other Entertainment, Darkness, National Survey on Drug Use and Health, Suds, Life, Face, Culture, Light, Woman, Multimedia, Drug overdose, Bare, Internet, The 39 Clues, SUD, SAMSHA, Pharmaceutical industry, Addiction

Launching as part of Overdose Awareness Week, Shatterproof invites anyone with tattoos inspired by addiction, recovery or the loss of a loved one to share the story behind their body art through a campaign called Bare Your Heart.

Key Points: 
  • Launching as part of Overdose Awareness Week, Shatterproof invites anyone with tattoos inspired by addiction, recovery or the loss of a loved one to share the story behind their body art through a campaign called Bare Your Heart.
  • View the full release here: https://www.businesswire.com/news/home/20230901039813/en/
    Led by Shatterproof , a national nonprofit organization focused on guiding communities, removing systemic barriers to recovery, mobilizing the country to advocate for change, and ending addiction stigma in the U.S., Bare Your Heart is a campaign that will raise awareness about the impact of addiction with new digital audiences.
  • With the launch of Bare Your Heart, Shatterproof is partnering with influencer and TikToker, Lonni Pike (@grayhairandtattoos), who has more than 30 tattoos and uses her platform to challenge the stereotypes placed on women in their fifties with tattoos.
  • "Through the Bare Your Heart campaign, we aim to celebrate the incredible power of self-expression and storytelling embodied in tattoos.

First-on-Podium Data from 20 Vascular and Venous Clinical Trials to Be Presented at The VEINS and VIVA 2023

Retrieved on: 
Wednesday, August 30, 2023
Learning, Wynn Las Vegas, Atherectomy, Subgroup analysis, Pivotal trial, Perfusion, VIVA, Bare, Physician, Vein, Blood vessel, Diagnosis, Patient, Moyamoya disease, Nursing, Birth control, Medical imaging

PALM SPRINGS, Calif., Aug. 30, 2023 /PRNewswire/ -- Leading physicians and researchers will present results from 20 clinical trials from Monday, October 30, to Wednesday, November 1, at the annual VIVA and The VEINS conferences at Wynn Las Vegas.

Key Points: 
  • PALM SPRINGS, Calif., Aug. 30, 2023 /PRNewswire/ -- Leading physicians and researchers will present results from 20 clinical trials from Monday, October 30, to Wednesday, November 1, at the annual VIVA and The VEINS conferences at Wynn Las Vegas.
  • VIVA (Vascular InterVentional Advances) is a vascular education symposium that emphasizes innovation and multidisciplinary learning.
  • The 2023 conference will mark VIVA's 21st anniversary as a premier educational event for peripheral vascular disease specialists.
  • The VEINS (Venous Endovascular INterventional Strategies) is a comprehensive symposium focused on the diagnosis, intervention, and management of venous disorders.

DEEPER OUS Trial Evaluating Reflow Medical’s Bare Temporary Spur Stent System Shows Positive Results at Six Months

Retrieved on: 
Tuesday, June 13, 2023
Health, Clinical Trials, Cardiology, Medical Devices, Medicine, Freedom, Senior, Calcification, Multimedia, Federal, Bare, MD, Patient, MALE, LINC, Research, Safety, POD, FESC, Angiology, Pharmaceutical industry, Telescopic sight, Medical device

Reflow Medical, Inc. announced the six-month results of the DEEPER OUS clinical trial (NCT03807531) evaluating the safety and efficacy of the Bare Temporary Spur Stent System.

Key Points: 
  • Reflow Medical, Inc. announced the six-month results of the DEEPER OUS clinical trial (NCT03807531) evaluating the safety and efficacy of the Bare Temporary Spur Stent System.
  • In 38 patients with a total of 40 lesions treated with the Bare Temporary Spur Stent System, results demonstrated:
    a trend toward improved six-month patency in subjects without vessel recoil.
  • Prof. Zeller discussed these and other results in his presentation, “DEEPER OUS trial - Vessel Recoil Sub-study: Initial Insights.”
    The Bare Temporary Spur Stent System is designed to deliver a temporary stent with integrated radial spikes to the peripheral vasculature via a sheathed delivery system, for stent-like results while leaving nothing behind.
  • “We’re looking forward to continuing to see great results from the study.”
    The Bare Temporary Spur Stent System is for investigational use only.

Powered by MRP Announces Attendance at the 42nd Annual Conference of the American Society for Laser Medicine and Surgery April 13th-16th

Retrieved on: 
Tuesday, April 11, 2023
Bela, Hair removal, Education, Booth, MRP, Elective surgery, Bare, Trust, Laser, Physician, GPO, Health, AEGIS, Society, Conference, EDGE, PARK

PARK CITY, Utah, April 11, 2023 /PRNewswire/ -- MRP.io ("MRP"), the first end-to-end marketplace for new and used aesthetics equipment, supplies, and services, announces the attendance at the upcoming 42nd Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS) in Phoenix, AZ, on April 13th-16th at Booth 102.

Key Points: 
  • PARK CITY, Utah, April 11, 2023 /PRNewswire/ -- MRP.io ("MRP"), the first end-to-end marketplace for new and used aesthetics equipment, supplies, and services, announces the attendance at the upcoming 42nd Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS) in Phoenix, AZ, on April 13th-16th at Booth 102.
  • In its fifth decade as a world leader in promoting excellence in patient care, the ASLMS conference advocates for advancing the biomedical application of lasers and energy-based technologies.
  • At the conference, MRP will showcase a full range of new and used brands and devices, including leading aesthetics laser companies – for which MRP is the exclusive distributor – Jeisys, LUVO, Perigee, and FineMec.
  • The Jeisys Lipocel HIFU for body contouring and fat reduction will be available at the MRP booth along with the EDGE CO2 and the INTRACEL RFMN.

First Patient Enrolled in Reflow Medical’s DEEPER REVEAL IDE Clinical Study

Retrieved on: 
Tuesday, November 1, 2022
Health, Clinical Trials, Cardiology, Medical Devices, Entrepreneurship, Intervention, IDE, Traction, CEO, FSVM, Skin, Advanced cardiac life support, Clinical trial, Hospital, Physician, Medicine, FACC, Safety, Bare, CLI, Cardiovascular disease, Technology, FDA, MS, Patient, Multimedia, ACV, Orange County, Solution, Trial of the century, Pharmaceutical industry, MD

Reflow Medical, Inc., a medical device company focused on cardiovascular disease, announces that the first patient was successfully treated and enrolled in the DEEPER REVEAL investigational device exemption (IDE) clinical trial (NCT05358353) at Advanced Cardiac & Vascular Centers (ACV) in Grand Rapids, Michigan.

Key Points: 
  • Reflow Medical, Inc., a medical device company focused on cardiovascular disease, announces that the first patient was successfully treated and enrolled in the DEEPER REVEAL investigational device exemption (IDE) clinical trial (NCT05358353) at Advanced Cardiac & Vascular Centers (ACV) in Grand Rapids, Michigan.
  • Were looking forward to enrolling our first patients in the DEEPER REVEAL study here in Florida.
  • Isa Rizk, CEO and Co-Founder of Reflow Medical, commented on enrolling the first patient in the DEEPER REVEAL study.
  • The DEEPER REVEAL trial continues to build on Reflow Medicals commitment to improving outcomes for patients suffering from critical limb ischemia, for which there are limited solutions to date.

Tree Hut Wins Prestigious 2022 Allure Best of Beauty Award

Retrieved on: 
Wednesday, September 14, 2022
Target, Walmart, Tree Hut, Bare, Lip, Beauty, Face, Social media, Vitamin E, Facebook, Instagram, Irritation, TikTok, Allure, Skin, Multimedia, Ulta, Cosmetics

COPPELL, Texas, Sept. 14, 2022 /PRNewswire/ -- From fandom to stardom, Tree Hut, the makers of America's No. 1 Body Scrubs, was honored with the highly coveted 2022 Allure Best of Beauty Award for its innovative Bare Moisturizing Shave Oil. An iconic staple in the beauty industry for 26 years, the Allure Best of Beauty Awards celebrates brands known for efficacy, excellence and integrity. Following months of testing thousands of beauty products, the Allure team recognized the Tree Hut Bare Moisturizing Shave Oil as the best product in the category for its formula, delivery system, texture and scent.

Key Points: 
  • 1 Body Scrubs, was honored with the highly coveted 2022 Allure Best of Beauty Award for its innovative Bare Moisturizing Shave Oil.
  • An iconic staple in the beauty industry for 26 years, the Allure Best of Beauty Awards celebrates brands known for efficacy, excellence and integrity.
  • Following months of testing thousands of beauty products, the Allure team recognized the Tree Hut Bare Moisturizing Shave Oil as the best product in the category for its formula, delivery system, texture and scent.
  • The Tree Hut Bare Moisturizing Shave Oil comes in classic Coconut Lime, Tahitian Vanilla, Moroccan Rose, Tropic Glow and now, Watermelon.

about-face Launches the Bare Necessities - Brilliant-Toned, Insanely-pigmented Neutral Additions to the Award-Winning Shadowsticks Franchise on June 7, 2022

Retrieved on: 
Tuesday, June 7, 2022
People, Human, MTV, Women's rights, The Bare Necessities, OG, Mental health, AMA, LGBTQ, Songwriters Hall of Fame, No, Bare Necessities, Halsey (singer), CMT Music Awards, Music, GLAAD Media Award, Billboard, Bare, Platinum, The New York Times Best Seller list, Grammy Awards, The Dream Syndicate, Hal, Collection, MTV VMA, CMT, TIME, Cosmetics, Poetry, Lotus, Manic

about-face drops award-winning Shadowsticks in 4 new, neutral-toned, pearly hues and the return of best-selling shades.

Key Points: 
  • about-face drops award-winning Shadowsticks in 4 new, neutral-toned, pearly hues and the return of best-selling shades.
  • "As one of the OG about-face products, Shadowsticks will always be a staple in my makeup kit," Halsey says.
  • "Whether on tour, or just on-the-go, this insanely-pigmented eyeshadow crayon is so easy to apply for simple lid cover, graphic lines and artistic looks.
  • Halsey continues to speak up for important causes such as disenfranchised youth, women's rights, mental health and the LGBTQ community.

Powered by MRP Announces Exclusive Agreement with LUVO Medical to Distribute Aesthetic Devices in the United States

Retrieved on: 
Thursday, December 23, 2021
808, Bela, Lucent, TLC, Sale, MRP, Aesthetics, PARK, GPO, VP, Catalog, Multimedia, Bare, Darwin, Partnership, Pharmaceutical industry, Video game

MRP founder and CEO Scott Carson stated, "This partnership is an amazing opportunity for Powered by MRP to get LUVO Medical products into the hands of clinicians in the United States for the first time."

Key Points: 
  • MRP founder and CEO Scott Carson stated, "This partnership is an amazing opportunity for Powered by MRP to get LUVO Medical products into the hands of clinicians in the United States for the first time."
  • MRP.io ("MRP") announced today that it has signed an exclusive agreement with LUVO Medical.
  • "We are thrilled to partner with MRP for the exclusive sale of four LUVO devices in the United States," said Kevin Noseworthy, VP of Sales at LUVO medical.
  • For additional information or to acquire any LUVO Medical products through MRP, please visit the MRP website: www.mrp.io .